as soon as i calculate the study by using my model, it loses its magic. i chose the base case and applied the other numbers according to rigi. the pfs says that 'capital costs funded with 100% equity (i.e., no financing costs assumed)'. i still modeled the financing of the project with 50% debt and 50% cr. the capex for 25kt is currently 11x of their current market capitalization. the pfs also assumes 100% ownership. if i apply the estimated carbonate price from fastmarkets (14,500 usd/t) to the pfs figures, i get an npv after tax of 128m usd (irr after tax of 9.2%).
regarding gln, if we assume a phased approach and a total capex for stage 2 of 428m for ~21kt lce (118m for 5,400t) and subtract the already ~40% completed stage 1, we get an open capex of ~360m usd. this corresponds to 7.4x of gln's current market capitalization. gln is superior in terms of raw numbers. so far it has passed the mathematical stress test against every other company. just my opinion. no financial advice. always do your own research.
- Forums
- ASX - By Stock
- GLN
- Argentine Brine Comparables
GLN
galan lithium limited
Add to My Watchlist
7.14%
!
10.5¢

Argentine Brine Comparables, page-99
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
10.5¢ |
Change
0.007(7.14%) |
Mkt cap ! $100.5M |
Open | High | Low | Value | Volume |
9.9¢ | 11.0¢ | 9.9¢ | $324.7K | 3.146M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14450 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 1334688 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14450 | 0.105 |
7 | 924000 | 0.100 |
6 | 88026 | 0.099 |
4 | 233267 | 0.098 |
1 | 25000 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 1263164 | 20 |
0.115 | 981249 | 15 |
0.120 | 1177837 | 7 |
0.125 | 317018 | 5 |
0.130 | 303000 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
GLN (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online